Answers are grounded in this paper and cite their sources.
These results indicate that the presence of anti-CADM-140 autoantibodies may be a novel marker for C-ADM. Further attention should be directed to the detection of rapidly progressive ILD in those patients with anti-CADM-140 autoantibodies.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: